Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
England’s NICE Cuts ‘Disproportionately High’ Cost For Industry In Revised Proposals For Updating COVID-19 Recommendations
Jul 03 2023
•
By
Neena Brizmohun
NICE wants feedback on its revised proposals for updating its COVID-19 guidances quickly • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United Kingdom
More from Europe